To assess the risk of breast cancer recurrence, breast cancer-specific mortality, and overall mortality for breast cancer survivors receiving vaginal estrogen therapy for genitourinary syndrome of menopause.
Program: Oral and Poster Abstracts Type: Oral Session: 654. Multiple Myeloma: Pharmacologic Therapies: Refining the Evidence: Randomized Trials in Multiple Myeloma Hematology Disease Topics &…
Program: Oral and Poster Abstracts Type: Oral Session: 654. Multiple Myeloma: Pharmacologic Therapies: Refining the Evidence: Randomized Trials in Multiple Myeloma Hematology Disease Topics &…
By Helen Cashman, Andrew J Wilson & 4 more. Our patient was a 36-year-old female who presented to hospital at 33 weeks pregnant with symptomatic…
Pfizer’s head of digital devices says the industry is close to a ‘revolution’ in using measures from wearables in clinical trials.
8,971 Followers, 823 Following, 40 Posts – See Instagram photos and videos from Mauricio Ambriz (@mauambriz)
Nature – We evaluated the use of chimeric antigen receptor-modified T cells targeting GD2 (GD2-CART) for H3K27M+ diffuse midline glioma (DMG), finding that intravenous administration of…
Nature – We evaluated the use of chimeric antigen receptor-modified T cells targeting GD2 (GD2-CART) for H3K27M+ diffuse midline glioma (DMG), finding that intravenous administration of…
A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the beginning.
By Ariela Marshall, MD, Adult Classical Hematologist, University of Minnesota You are not the only architect of your success, but you DO need to be…
Venetoclax in combination with hypomethylating agents in chronic myelomonocytic leukemia: a propensity score matched multicenter cohort study
